| Dr Seshu Chepur Rao, MD | |
|
929 Sw Mulvane St, Topeka, KS 66606-1677 | |
| (785) 270-4100 | |
| (785) 270-4177 |
| Full Name | Dr Seshu Chepur Rao |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 17 Years |
| Location | 929 Sw Mulvane St, Topeka, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194757815 | NPI | - | NPPES |
| 201073680A | Medicaid | KS | |
| 068002215 | Other | KS | MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 04-36467 (Kansas) | Secondary |
| 207RI0011X | Internal Medicine - Interventional Cardiology | 04-36467 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Stormont Vail Hospital | Topeka, KS | Hospital |
| Ascension Via Christi Hospital Manhattain, Inc | Manhattan, KS | Hospital |
| Geary Community Hospital | Junction city, KS | Hospital |
| Holton Community Hospital | Holton, KS | Hospital |
| Great Plains Of Sabetha | Sabetha, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cotton O'neil Clinic Revocable Trust | 5496659195 | 576 |
News Archive
The Associated Press reports on the emergence of concerns regarding the health law and drug cost disparities. Meanwhile, other news outlets report on how employers continue to have angst about the measure's price tag.
ISTA Pharmaceuticals, Inc. has announced results from the Company's recently completed Phase III clinical program of Xibrom (0.09% bromfenac sodium ophthalmic solution) QD (once-daily).
The research - commissioned by Superdrug and Cancer Research UK as part of their joint campaign to encourage people to enjoy the sun safely this summer - highlights the worrying lengths sun-seeking Brits are prepared to go to in search of a tan.
Medgenics, Inc., developer of the novel Biopump technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced receipt of clearance from the U.S. Food and Drug Administration to proceed with a Phase IIb clinical trial of EPODURE for the treatment of anemia in patients undergoing renal dialysis.
› Verified 7 days ago
| Entity Name | Cotton O'neil Clinic Revocable Trust |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811944457 PECOS PAC ID: 5496659195 Enrollment ID: O20031124000674 |
News Archive
The Associated Press reports on the emergence of concerns regarding the health law and drug cost disparities. Meanwhile, other news outlets report on how employers continue to have angst about the measure's price tag.
ISTA Pharmaceuticals, Inc. has announced results from the Company's recently completed Phase III clinical program of Xibrom (0.09% bromfenac sodium ophthalmic solution) QD (once-daily).
The research - commissioned by Superdrug and Cancer Research UK as part of their joint campaign to encourage people to enjoy the sun safely this summer - highlights the worrying lengths sun-seeking Brits are prepared to go to in search of a tan.
Medgenics, Inc., developer of the novel Biopump technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced receipt of clearance from the U.S. Food and Drug Administration to proceed with a Phase IIb clinical trial of EPODURE for the treatment of anemia in patients undergoing renal dialysis.
› Verified 7 days ago
| Entity Name | Stormont Vail Health Flint Hills Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952018608 PECOS PAC ID: 9032587472 Enrollment ID: O20230429000051 |
News Archive
The Associated Press reports on the emergence of concerns regarding the health law and drug cost disparities. Meanwhile, other news outlets report on how employers continue to have angst about the measure's price tag.
ISTA Pharmaceuticals, Inc. has announced results from the Company's recently completed Phase III clinical program of Xibrom (0.09% bromfenac sodium ophthalmic solution) QD (once-daily).
The research - commissioned by Superdrug and Cancer Research UK as part of their joint campaign to encourage people to enjoy the sun safely this summer - highlights the worrying lengths sun-seeking Brits are prepared to go to in search of a tan.
Medgenics, Inc., developer of the novel Biopump technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced receipt of clearance from the U.S. Food and Drug Administration to proceed with a Phase IIb clinical trial of EPODURE for the treatment of anemia in patients undergoing renal dialysis.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Seshu Chepur Rao, MD 929 Sw Mulvane St, Topeka, KS 66606-1677 Ph: (785) 270-4100 | Dr Seshu Chepur Rao, MD 929 Sw Mulvane St, Topeka, KS 66606-1677 Ph: (785) 270-4100 |
News Archive
The Associated Press reports on the emergence of concerns regarding the health law and drug cost disparities. Meanwhile, other news outlets report on how employers continue to have angst about the measure's price tag.
ISTA Pharmaceuticals, Inc. has announced results from the Company's recently completed Phase III clinical program of Xibrom (0.09% bromfenac sodium ophthalmic solution) QD (once-daily).
The research - commissioned by Superdrug and Cancer Research UK as part of their joint campaign to encourage people to enjoy the sun safely this summer - highlights the worrying lengths sun-seeking Brits are prepared to go to in search of a tan.
Medgenics, Inc., developer of the novel Biopump technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced receipt of clearance from the U.S. Food and Drug Administration to proceed with a Phase IIb clinical trial of EPODURE for the treatment of anemia in patients undergoing renal dialysis.
› Verified 7 days ago
Dr. Jerry R. Majers, D.O. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2200 Sw Gage Blvd, Topeka, KS 66622 Phone: 785-350-3111 | |
James Patrick Birkbeck, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 929 Sw Mulvane St, Topeka, KS 66606 Phone: 785-270-4100 | |
Dr. Steven E Seals, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 929 Sw Mulvane St, Topeka, KS 66606 Phone: 785-270-4100 Fax: 785-270-4202 | |
John L Joliff, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Sw College Ave, Topeka, KS 66606 Phone: 784-233-9643 Fax: 785-233-6821 | |
Amarinder Pal Singh, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1700 Sw 7th Street, Topeka, KS 66606 Phone: 785-295-8000 Fax: 785-231-5988 | |
Dr. Craig F Gernon, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 929 Sw Mulvane St, Topeka, KS 66606 Phone: 785-270-4100 Fax: 785-270-4177 | |
Bradley W Marples, Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 901 Sw Garfield Ave, Topeka, KS 66606 Phone: 785-354-9595 |